Relapsing toxic epidermal necrolysis following COVID-19
- PMID: 39430626
- PMCID: PMC11488411
- DOI: 10.1016/j.jdcr.2024.07.011
Relapsing toxic epidermal necrolysis following COVID-19
Keywords: COVID-19; SJS; Stevens-Johnson syndrome; TEN; relapsing; toxic epidermal necrolysis.
Conflict of interest statement
Dr Min is on the advisory boards of Horizon, McGraw Hill, and BMS and is an investigator for Amgen, BI, MBS, and Priovant. Dr Rojek has served on the advisory board of Boehringer Ingelheim. The other authors have no conflicts of interest to declare.
Figures


References
-
- Malviya M., Barua S., Shenoy M.A., Ullah A.M. Paxlovid-associated Stevens-Johnson syndrome. Chest J. 2023;164(4):A2062–A2063. doi: 10.1016/j.chest.2023.07.1410. - DOI
Publication types
LinkOut - more resources
Full Text Sources